| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JHEP.2005.01.030 |
| P698 | PubMed publication ID | 15885356 |
| P50 | author | David A. Brenner | Q44296012 |
| P2093 | author name string | John K Westwick | |
| Graham K Bilter | |||
| Tetsuya Uehara | |||
| Yoshitaka Satoh | |||
| Brydon Bennett | |||
| Steve T Sakata | |||
| P433 | issue | 6 | |
| P921 | main subject | reperfusion injury | Q1413991 |
| P304 | page(s) | 850-859 | |
| P577 | publication date | 2005-04-07 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | JNK mediates hepatic ischemia reperfusion injury | |
| P478 | volume | 42 |
| Q48932792 | 10th anniversary Inflammation and Immune Diseases Drug Discovery and Development Summit. 20-21 March 2006, New Brunswick, USA. |
| Q28392033 | A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches |
| Q38230663 | A review of melatonin in hepatic ischemia/reperfusion injury and clinical liver disease. |
| Q45174582 | Ambroxol alleviates hepatic ischemia reperfusion injury by antioxidant and antiapoptotic pathways |
| Q39069150 | Anticarcinogenic effects of the ethanolic extract of Salix aegyptiaca in colon cancer cells: involvement of Akt/PKB and MAPK pathways. |
| Q36382247 | Apoptosis and necrosis in the liver: a tale of two deaths? |
| Q46221482 | Beneficial effects of green tea catechin on massive hepatectomy model in rats |
| Q60048845 | Beraprost sodium preconditioning prevents inflammation, apoptosis, and autophagy during hepatic ischemia-reperfusion injury in mice via the P38 and JNK pathways |
| Q46269173 | Biochemical targets of drugs mitigating oxidative stress via redox-independent mechanisms |
| Q36077176 | C-Jun N-Terminal Kinase 2 Promotes Liver Injury via the Mitochondrial Permeability Transition after Hemorrhage and Resuscitation |
| Q35219027 | CXC chemokine signaling in the liver: impact on repair and regeneration |
| Q46880127 | CXCL10 regulates liver innate immune response against ischemia and reperfusion injury |
| Q38789891 | CYP2E1 Sensitizes the Liver to LPS- and TNF α-Induced Toxicity via Elevated Oxidative and Nitrosative Stress and Activation of ASK-1 and JNK Mitogen-Activated Kinases |
| Q33911157 | CYP2E1 potentiation of LPS and TNFα-induced hepatotoxicity by mechanisms involving enhanced oxidative and nitrosative stress, activation of MAP kinases, and mitochondrial dysfunction |
| Q38237868 | Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus |
| Q46917285 | Chronic lithium treatment protects against liver ischemia/reperfusion injury in rats |
| Q83984819 | Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury |
| Q54584941 | Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. |
| Q41396770 | Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure |
| Q36221269 | Critical role of c-jun N-terminal protein kinase in promoting mitochondrial dysfunction and acute liver injury |
| Q36134951 | Cutaneous manifestations of systemic lupus erythematosus. |
| Q36312529 | Death by association: BH3 domain-only proteins and liver injury |
| Q42974185 | Delayed ischemic preconditioning protects against liver ischemia-reperfusion injury in vivo |
| Q37038490 | Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance |
| Q46937417 | Differential regulation of the JNK/AP-1 pathway by S-adenosylmethionine and methylthioadenosine in primary rat hepatocytes versus HuH7 hepatoma cells. |
| Q41764934 | Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase. |
| Q51000997 | Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway. |
| Q47761388 | Effect of cell permeable peptide of c-Jun NH2-terminal kinase inhibitor on the attenuation of renal ischemia-reperfusion injury in pigs |
| Q35675464 | Endogenous interleukin-4 regulates glutathione synthesis following acetaminophen-induced liver injury in mice |
| Q47282915 | Exogenous biliverdin ameliorates ischemia-reperfusion injury in small-for-size rat liver grafts |
| Q61810426 | Gene Expression Profiling in Ischemic Postconditioning to Alleviate Mouse Liver Ischemia/Reperfusion Injury |
| Q27327201 | HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury |
| Q37832543 | Hepatic ischemia-reperfusion injury and therapeutic strategies to alleviate cellular damage |
| Q34147508 | Hepatocyte Death: A Clear and Present Danger |
| Q61796045 | Indispensable role of β-arrestin2 in the protection of remifentanil preconditioning against hepatic ischemic reperfusion injury |
| Q28387669 | Inflammation- and stress-related signaling pathways in hepatocarcinogenesis |
| Q42926782 | Inhibition of Endogenous Hedgehog Signaling Protects Against Acute Liver Injury After Ischemia Reperfusion |
| Q33699704 | Inhibition of hepatic mitochondrial aldehyde dehydrogenase by carbon tetrachloride through JNK-mediated phosphorylation |
| Q46735658 | Inhibition of intestinal ischemia/repurfusion induced apoptosis and necrosis via down-regulation of the NF-kB, c-Jun and caspace-3 expression by epigallocatechin-3-gallate administration. |
| Q33304105 | Inhibitors of c-Jun N-terminal kinases: JuNK no more? |
| Q36252429 | Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells |
| Q48956051 | Involvement of the dual-specificity phosphatase M3/6 in c-Jun N-terminal kinase inactivation following cerebral ischemia in the rat hippocampus |
| Q80188311 | Ischemic preconditioning of the murine liver protects through the Akt kinase pathway |
| Q34713366 | JNK signaling in apoptosis |
| Q54433786 | JNK signalling in human and experimental renal ischaemia/reperfusion injury. |
| Q47265464 | JNK, p38, ERK, and SGK1 Inhibitors in Cancer. |
| Q36672281 | JunD protects the liver from ischemia/reperfusion injury by dampening AP-1 transcriptional activation |
| Q42800188 | Mark4 promotes adipogenesis and triggers apoptosis in 3T3-L1 adipocytes by activating JNK1 and inhibiting p38MAPK pathways |
| Q36421523 | Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways |
| Q38792105 | Melatonin role preventing steatohepatitis and improving liver transplantation results |
| Q34182691 | Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597) |
| Q50177417 | Mild Hypothermia Pretreatment Attenuates Liver Ischemia Reperfusion Injury Through Inhibiting c-Jun NH2-terminal Kinase Phosphorylation in Rats |
| Q26824709 | Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications |
| Q37130649 | Mitochondrial permeability transition in liver ischemia and reperfusion: role of c-Jun N-terminal kinase 2. |
| Q64059701 | Mitogen Activated Protein Kinases in Steatotic and Non-Steatotic Livers Submitted to Ischemia-Reperfusion |
| Q41707732 | Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition |
| Q28384866 | Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK |
| Q36219461 | Nilotinib protects the murine liver from ischemia/reperfusion injury |
| Q28476642 | Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice |
| Q37002521 | Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion |
| Q40642702 | Phosphorylation of Bad at Thr-201 by JNK1 promotes glycolysis through activation of phosphofructokinase-1. |
| Q57115227 | Post-reperfusion hydrogen gas treatment ameliorates ischemia reperfusion injury in rat livers from donors after cardiac death: a preliminary study |
| Q47681053 | Potential role of IL-37 in atherosclerosis |
| Q35919883 | Protection of rat intestinal epithelial cells from ischemia/reperfusion injury by (D-Ala2, D-Leu5)-enkephalin through inhibition of the MKK7-JNK signaling pathway |
| Q36600431 | Protective effect of carbon monoxide in transplantation |
| Q36758015 | Protective mechanisms of hypothermia in liver surgery and transplantation. |
| Q38795156 | Protective role of silent information regulator 1 against hepatic ischemia: effects on oxidative stress injury, inflammatory response, and MAPKs. |
| Q37211896 | Protein kinases in organ ischemia and reperfusion |
| Q34009236 | Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver |
| Q30407113 | Regulation of molecular pathways in ischemia-reperfusion injury after liver transplantation |
| Q55070768 | Reviews of Interleukin-37: Functions, Receptors, and Roles in Diseases. |
| Q51653926 | Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development. |
| Q87742404 | Saponins isolated from Schizocapsa plantaginea inhibit human hepatocellular carcinoma cell growth in vivo and in vitro via mitogen-activated protein kinase signaling |
| Q38587788 | Selectins in Liver Ischemia and Reperfusion Injury. |
| Q46105928 | Signaling pathway on the effect of oxygenated warm perfusion prior to cold preservation of the liver grafts from non-heart-beating donors, and the additive effect of edaravone |
| Q37561307 | Sirtuin 2 aggravates postischemic liver injury by deacetylating mitogen-activated protein kinase phosphatase-1. |
| Q92493137 | Six-Transmembrane Epithelial Antigen of the Prostate 3 Deficiency in Hepatocytes Protects the Liver Against Ischemia-Reperfusion Injury by Suppressing Transforming Growth Factor-β-Activated Kinase 1 |
| Q36291138 | TRAF1 is a key mediator for hepatic ischemia/reperfusion injury |
| Q30500831 | The c-jun kinase/stress-activated pathway: regulation, function and role in human disease |
| Q35751876 | The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling |
| Q79438927 | The effect of perfusion prior to cold preservation and addition of biliverdin on the liver graft from non-heart-beating donors |
| Q37317154 | The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo |
| Q54626173 | The role of excessive versus acute administration of erythropoietin in attenuating hepatic ischemia-reperfusion injury. |
| Q38052410 | Therapeutic role of toll-like receptor modification in cardiovascular dysfunction |
| Q51610722 | Thrombomodulin Attenuates Inflammatory Damage Due to Liver Ischemia and Reperfusion Injury in Mice in Toll-Like Receptor 4-Dependent Manner. |
| Q28301962 | Wiring the cell signaling circuitry by the NF-kappa B and JNK1 crosstalk and its applications in human diseases |
| Q89621699 | c-Jun N-Terminal Kinase Signaling Inhibitors Under Development |
Search more.